
Researchers have determined that there is moderate quality evidence suggesting that aerobic exercise as prophylactic treatment can decrease the number of migraine days among patients with migraine.


Researchers have determined that there is moderate quality evidence suggesting that aerobic exercise as prophylactic treatment can decrease the number of migraine days among patients with migraine.

A new study has indicated that patients who experience late onset migraine with aura (MA) may be at an increased risk of ischemic stroke in late life despite having a shorter history of MA.

Results from a recent study showed that only age affects cortical thickness or volume, and intracranial volume affects cortical volume in migraine.

Hoping to clarify the pathogenic mechanism that underlies migraine attacks triggered by sound, researchers have identified specific signal components associated with unpleasantness for patients with migraine.

A recent study using the 2016 genome-wide association study (GWAS) identified that vascular mechanisms, but also neuronal and metal ion homeostasis, may play a role in migraine susceptibility.

Here are the top 5 articles for the month of January.

The FDA has approved sumatriptan nasal spray (Tosymra) for the acute treatment of migraine with or without aura in adults.

Nonheadache and headache specialists have moderate levels of agreement in classifying common chronic headache disorders after using the telephone classification interview model, according to a study.



Among people with obesity, those with migraine have greater total healthcare utilization and expenses compared with those without migraine.

https://www.pharmacytimes.org/on-demand/an-american-journal-of-managed-care-ajmc-2part-supplement-current-new-and-emerging-therapies-for-the-prevention-and-management-of-migraine

Patients who have 4 or more migraine days per month and have failed on prophylactic treatment experience reduced quality of life, work productivity, and social activity involvement.

Providing healthcare professionals with up-to-date guidance for the use of preventive and acute treatments for migraine, the American Headache Society has published a consensus statement outlining indications for initiating, continuing, combining, and switching the treatments.

Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.

An analysis of 6 studies found an increased risk of all-cause dementia among patients with any headache. However, no association was found between headache and Alzheimer disease.

Patients with migraine, patent foramen ovale (PFO), and atrial septal aneurysm (ASA) have more frequent ischemic brain lesions, migraine with aura, and larger PFO sizes than patients with migraines and PFO without ASA, according to the results of a recent study.

A meta-analysis of 17 studies finds that botulinum toxin (Botox) is superior to placebo for the prophylactic treatment of chronic migraine.

Patients with a history of migraine are more likely to develop spontaneous coronary artery dissection at a younger age, have depression, and post-SCAD chest pains compared with patients without a migraine history, according to the results of a recent study.

Researchers have found that sleep disorders, especially insomnia, can impact the prevalence of migraine.

A study of more than 2000 people with migraine found that red wine was singled out most frequently as a cause of migraine attacks, whereas vodka was indicated least frequently.

A study found an approximate 30% decrease in the risk of developing type 2 diabetes among women with active migraine.

Data from 3 erenumab clinical trials of patients with migraine have identified that an increase in the frequency of monthly migraine days leads to an increase in acute medication use and productivity loss.

The project will initially focus on improving patient outcomes for 2 conditions: osteoporosis and migraine.

Exmaning an assessment of data from the 2016 Global Burden of Diseases, Injuries, and Risk Factors study, researchers found that headache disorders, specifically migraine, are important causes of disability worldwide and therefore require more attention in health policy debates and greater resources for research.

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512
© 2025 MJH Life Sciences®
All rights reserved.
